How It Works
Answer a Few Questions
Provide information about age, diagnosis, symptoms, and genetic testing status.
Get Your Results
Receive a preliminary eligibility assessment based on your answers.
Connect with Our Team
If potentially eligible, speak with our research team to learn more about next steps.
About Glycomine Clinical Trials
Glycomine is developing replacement therapies for rare genetic diseases with the goal of delivering meaningful improvements in quality of life for patients, caregivers, and families.
NGLY1 Deficiency
Clinical trials for patients with confirmed genetic diagnosis of NGLY1 deficiency.
PGAP3 Deficiency
Research studies for patients with confirmed PGAP3 genetic mutations.
Other Rare Diseases
Upcoming trials for additional ultra-rare genetic disorders.
About Glycomine
Glycomine is developing replacement therapies for rare genetic diseases with the goal of delivering meaningful improvements in quality of life for patients, caregivers, and families.
Our mission is to become the leading company in developing treatments for rare diseases by focusing on the underlying causes and addressing the most challenging symptoms.
Our Focus
- Developing novel therapies for ultra-rare genetic disorders
- Conducting rigorous clinical trials to ensure safety and efficacy
- Supporting patients and families throughout their journey
- Advancing scientific understanding of rare genetic diseases